Clinical Trial to Assess the Effectiveness of I+Med's DayDrop Advanced Ophthalmic Drop

Launched by I+MED S.COOP. · Dec 12, 2024

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients of both sexes over 18 years of age.
• • Patients diagnosed with mild-moderate dry eye who meet the following characteristics: Schirmer test ≥3 and ≤ 10 mm; BUT test ≥5 and ≤ 10 seconds and OSDI ≥13 and ≤ 33.
• • Patients without other ophthalmologic pathologies.
• • Have ability to self-administer drops.
• • Have ability to understand the Patient Information Sheet.
• • Sign the Informed Consent.
• Exclusion Criteria:
• • Patients diagnosed with severe dry eye.
• • Ingestion of parasympathomimetic or antipsychotic medications .
• • Glaucoma.
• • Previous cataract surgery.
• • Systemic treatment with corticosteroids or topical treatment with any ophthalmic medication except artificial tears in the week prior to the start of study treatment.
• • Ocular infection or clinically significant inflammation.
• • Ocular surgery in the 3 months prior to the study.
• • Sjögren's syndrome.
• • Stevens-Johnson syndrome.
• • History of allergic conjunctivitis.
• • Pregnancy or planned lactation.